Terms: = Colorectal cancer AND CDKN2A, CDK4I, 1029, ENSG00000147889, P42771, p14, CMM2, ARF, TP16, p16, MTS1, p19, p16INK4a, INK4a, CDKN2, p16INK4, p14ARF, MLM, INK4
1030 results:
1. Therapy-induced senescent tumor cell-derived extracellular vesicles promote colorectal cancer progression through SERPINE1-mediated NF-κB p65 nuclear translocation.
Zhang D; Zhang JW; Xu H; Chen X; Gao Y; Jiang HG; Wang Y; Wu H; Yang L; Wang WB; Dai J; Xia L; Peng J; Zhou FX
Mol Cancer; 2024 Apr; 23(1):70. PubMed ID: 38576002
[TBL] [Abstract] [Full Text] [Related]
2. Methylation study of tumor suppressor genes in human aberrant crypt foci, colorectal carcinomas, and normal colon.
Sarangi J; Das P; Ahmad A; Sulaiman M; Ghosh S; Gupta B; Panwar R; Pal S; Yadav R; Ahuja V; Sen S; Upadhyay AD; Dash NR; Sharma A; Gupta SD
J Cancer Res Ther; 2024 Jan; 20(1):268-274. PubMed ID: 38554332
[TBL] [Abstract] [Full Text] [Related]
3. Epigenetic MLH1 silencing concurs with mismatch repair deficiency in sporadic, naturally occurring colorectal cancer in rhesus macaques.
Deycmar S; Johnson BJ; Ray K; Schaaf GW; Ryan DP; Cullin C; Dozier BL; Ferguson B; Bimber BN; Olson JD; Caudell DL; Whitlow CT; Solingapuram Sai KK; Romero EC; Villinger FJ; Burgos AG; Ainsworth HC; Miller LD; Hawkins GA; Chou JW; Gomes B; Hettich M; Ceppi M; Charo J; Cline JM
J Transl Med; 2024 Mar; 22(1):292. PubMed ID: 38504345
[TBL] [Abstract] [Full Text] [Related]
4. Cellular senescence is associated with the spatial evolution toward a higher metastatic phenotype in colorectal cancer.
Park SS; Lee YK; Choi YW; Lim SB; Park SH; Kim HK; Shin JS; Kim YH; Lee DH; Kim JH; Park TJ
Cell Rep; 2024 Mar; 43(3):113912. PubMed ID: 38446659
[TBL] [Abstract] [Full Text] [Related]
5. Villosol reverses 5-FU resistance in colorectal cancer by inhibiting the cdkn2a gene regulated TP53-PI3K/Akt signaling axis.
Chen H; Deng J; Hou TW; Shan YQ
J Ethnopharmacol; 2024 May; 325():117907. PubMed ID: 38342156
[TBL] [Abstract] [Full Text] [Related]
6. Primary vulvar adenocarcinoma of intestinal type: Report of two cases showing molecular similarity with colorectal adenocarcinoma.
Mateoiu C; Palicelli A; Maloberti T; De Biase D; De Leo A; Lindh M; Bohlin KS; Stolnicu S
Pathol Res Pract; 2024 Mar; 255():155181. PubMed ID: 38340583
[TBL] [Abstract] [Full Text] [Related]
7. Anal and Perianal Preneoplastic Lesions.
Loughrey MB; Shepherd NA
Gastroenterol Clin North Am; 2024 Mar; 53(1):201-220. PubMed ID: 38280748
[TBL] [Abstract] [Full Text] [Related]
8. Microsatellite Instability Is Insufficiently Used as a Biomarker for Lynch Syndrome Testing in Clinical Practice.
Papadopoulou E; Rigas G; Fountzilas E; Boutis A; Giassas S; Mitsimponas N; Daliani D; Ziogas DC; Liontos M; Ramfidis V; Christophilakis C; Matthaios D; Floros T; Florou-Chatzigiannidou C; Agiannitopoulos K; Meintani A; Tsantikidi A; Katseli A; Potska K; Tsaousis G; Metaxa-Mariatou V; Nasioulas G
JCO Precis Oncol; 2024 Jan; 8():e2300332. PubMed ID: 38271656
[TBL] [Abstract] [Full Text] [Related]
9. Risk factors of unintentional piecemeal resection in endoscopic mucosal resection for colorectal polyps ≥ 10 mm.
Ishikawa T; Okimoto K; Matsumura T; Ogasawara S; Fukuda Y; Kitsukawa Y; Yokoyama Y; Kanayama K; Akizue N; Iino Y; Ohta Y; Ishigami H; Taida T; Tsuchiya S; Saito K; Kamezaki H; Kobayashi A; Kikuchi Y; Tada M; Shiko Y; Ozawa Y; Kato J; Yamaguchi T; Kato N
Sci Rep; 2024 Jan; 14(1):493. PubMed ID: 38177176
[TBL] [Abstract] [Full Text] [Related]
10. Safety, feasibility, and short-term-outcome of anal endoscopic submucosal dissection for anal intraepithelial neoplasia: an option for focal lesions?
Singhartinger F; Gantschnigg A; Holzinger J; Wagner A; Singhartinger J; Koch O; Emmanuel K; Presl J
Tech Coloproctol; 2023 Dec; 28(1):18. PubMed ID: 38102514
[TBL] [Abstract] [Full Text] [Related]
11. Integrative analysis of single-cell and bulk RNA seq to reveal the prognostic model and tumor microenvironment remodeling mechanisms of cuproptosis-related genes in colorectal cancer.
Chu B; Wang Y; Yang J; Dong B
Aging (Albany NY); 2023 Dec; 15(23):14422-14444. PubMed ID: 38078879
[TBL] [Abstract] [Full Text] [Related]
12. Genetic profile of Chinese patients with small bowel cancer categorized by anatomic location.
Shi C; Ma J; Zhang T; Shi Y; Duan W; Huang D; Zhang H; Zeng Y
BMC Med Genomics; 2023 Nov; 16(1):289. PubMed ID: 37974218
[TBL] [Abstract] [Full Text] [Related]
13. High expression of cdkn2a is associated with poor prognosis in colorectal cancer and may guide PD-1-mediated immunotherapy.
Dong Y; Zheng M; Wang X; Yu C; Qin T; Shen X
BMC Cancer; 2023 Nov; 23(1):1097. PubMed ID: 37950153
[TBL] [Abstract] [Full Text] [Related]
14. Evaluation of rs10811661 polymorphism in cdkn2a / B in colon and gastric cancer.
Beihaghi M; Sahebi R; Beihaghi MR; Nessiani RK; Yarasmi MR; Gholamalizadeh S; Shahabnavaie F; Shojaei M
BMC Cancer; 2023 Oct; 23(1):985. PubMed ID: 37845622
[TBL] [Abstract] [Full Text] [Related]
15. Targeting IL-23 for the interception of obesity-associated colorectal cancer.
Madka V; Chiliveru S; Panneerselvam J; Pathuri G; Zhang Y; Stratton N; Kumar N; Sanghera DK; Rao CV
Neoplasia; 2023 Nov; 45():100939. PubMed ID: 37813000
[TBL] [Abstract] [Full Text] [Related]
16. Increased Incidence of Liver Metastases in colorectal
Garrett C; Cristaudo A; Barat S; Morris DL
Anticancer Res; 2023 Oct; 43(10):4657-4662. PubMed ID: 37772565
[TBL] [Abstract] [Full Text] [Related]
17. A novel cuproptosis-related gene prognostic signature in colon adenocarcinoma.
Su Y; Zhang K
Can J Physiol Pharmacol; 2023 Nov; 101(11):589-598. PubMed ID: 37698225
[TBL] [Abstract] [Full Text] [Related]
18. Peficitinib ameliorates 5-fluorouracil-induced intestinal damage by inhibiting aging, inflammatory factors and oxidative stress.
He S; Xia J; Jia H; Dai Q; Chen C; Zhou Y; Wang XB
Int Immunopharmacol; 2023 Oct; 123():110753. PubMed ID: 37572505
[TBL] [Abstract] [Full Text] [Related]
19. Construction and validation of a prognostic model for colon adenocarcinoma based on bile acid metabolism-related genes.
Luo Q; Zhou P; Chang S; Huang Z; Zeng X
Sci Rep; 2023 Aug; 13(1):12728. PubMed ID: 37543674
[TBL] [Abstract] [Full Text] [Related]
20. PTPN9 dephosphorylates FGFR2 pY656/657 through interaction with ACAP1 and ameliorates pemigatinib effect in cholangiocarcinoma.
Zhao L; Liu J; Li K; Zhang C; Chen T; Liu Z; Tang Y; Hu X; Shi A; Shu L; Huang S; Lian S; Zhang M; Li H; Sun J; Yu X; Zhang Z; Zhang Z; Xu Y
Hepatology; 2024 Apr; 79(4):798-812. PubMed ID: 37505213
[TBL] [Abstract] [Full Text] [Related]
[Next]
